| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.5% | +28% | $25,832,640 | +$6,202,560 | 1,516,000 | +32% | Armistice Capital, LLC | 31 Mar 2025 |
| BlackRock, Inc. | 7.7% | -22% | $23,548,990 | -$6,238,753 | 1,381,983 | -21% | BlackRock, Inc. | 31 Mar 2025 |
| Soleus Capital Master Fund, L.P. | 3.7% | -45% | $12,544,244 | -$9,006,498 | 658,145 | -42% | Soleus Capital Master Fund, L.P. | 30 Jun 2025 |
| MORGAN STANLEY | 0.7% | $3,297,817 | 116,406 | Morgan Stanley | 30 Sep 2025 | |||
| Invesco Ltd. | 0% | $109,891 | 6,449 | Invesco Ltd. | 31 Dec 2024 |
As of 30 Sep 2025, 164 institutional investors reported holding 14,988,939 shares of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL). This represents 90% of the company’s total 16,629,429 outstanding shares.
The largest institutional shareholders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10% | 1,724,898 | +6.1% | 0% | $48,866,361 |
| VANGUARD GROUP INC | 6.3% | 1,043,123 | -0.93% | 0% | $29,551,674 |
| GOLDMAN SACHS GROUP INC | 4.4% | 737,035 | +304% | 0% | $20,880,201 |
| ARMISTICE CAPITAL, LLC | 4.4% | 724,000 | -55% | 0.64% | $20,510,920 |
| ACADIAN ASSET MANAGEMENT LLC | 4.1% | 685,718 | +10% | 0.03% | $19,413,000 |
| MARSHALL WACE, LLP | 3.6% | 601,333 | +63% | 0.02% | $17,035,765 |
| Capitolis Liquid Global Markets LLC | 3.6% | 591,553 | 0% | 0.13% | $16,758,696 |
| STATE STREET CORP | 3.3% | 554,318 | -7.6% | 0% | $15,703,829 |
| RENAISSANCE TECHNOLOGIES LLC | 2.9% | 474,209 | +101% | 0.02% | $13,434,341 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 423,723 | +2% | 0% | $12,006,458 |
| Qube Research & Technologies Ltd | 2.2% | 360,966 | +111% | 0.01% | $10,226,167 |
| Soleus Capital Management, L.P. | 2% | 330,010 | -50% | 0.5% | $9,349,183 |
| JANE STREET GROUP, LLC | 1.9% | 321,894 | +1757% | 0.01% | $9,119,257 |
| D. E. Shaw & Co., Inc. | 1.8% | 306,489 | 0.01% | $8,682,833 | |
| Hillsdale Investment Management Inc. | 1.7% | 284,394 | +8.5% | 0.24% | $8,056,882 |
| JANUS HENDERSON GROUP PLC | 1.4% | 230,722 | 0% | $6,536,354 | |
| Connor, Clark & Lunn Investment Management Ltd. | 1.4% | 228,395 | +54% | 0.02% | $6,470,430 |
| CM Management, LLC | 1.4% | 225,000 | -10% | 5.3% | $6,374,250 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 220,298 | +475% | 0.01% | $6,241,042 |
| GLOBEFLEX CAPITAL L P | 1.3% | 217,630 | +30% | 0.95% | $6,165,458 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 209,387 | +35% | 0% | $5,933,012 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.1% | 186,326 | +748% | 0% | $5,278,616 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 179,808 | +132% | 0% | $5,093,961 |
| Squarepoint Ops LLC | 1% | 172,638 | +377% | 0.01% | $4,890,835 |
| Trexquant Investment LP | 1% | 167,118 | 0.05% | $4,734,453 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 174,000 | $7,452,569 | +$1,936,743 | $42.83 | 10 |
| 2025 Q3 | 14,988,939 | $424,669,287 | +$32,615,936 | $28.33 | 164 |
| 2025 Q2 | 13,883,445 | $260,032,689 | +$336,297 | $18.73 | 121 |
| 2025 Q1 | 13,902,025 | $250,095,826 | +$32,047,905 | $17.99 | 118 |
| 2024 Q4 | 12,067,467 | $202,977,079 | +$2,514,722 | $16.82 | 114 |
| 2024 Q3 | 11,904,852 | $192,606,155 | +$27,253,209 | $16.18 | 89 |
| 2024 Q2 | 10,378,502 | $85,309,167 | +$85,148,002 | $8.22 | 81 |